BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36389)

  • 21. Bis(monoacylglycero)phosphate in alkalophilic bacteria.
    Nishihara M; Morii H; Koga Y
    J Biochem; 1982 Nov; 92(5):1469-79. PubMed ID: 7153211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A lysosomal enzyme involved in diphosphatidylglycerol degradation.
    Werchola GM; Mellors A
    Lipids; 1981 Feb; 16(2):149-53. PubMed ID: 6264263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
    Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
    J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal bis (monoacylglycero)phosphate of rat liver, its induction by chloroquine and its structure.
    Tjiong HB; Debuch H
    Hoppe Seylers Z Physiol Chem; 1978 Jan; 359(1):71-9. PubMed ID: 627403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase.
    Medoh UN; Hims A; Chen JY; Ghoochani A; Nyame K; Dong W; Abu-Remaileh M
    Science; 2023 Sep; 381(6663):1182-1189. PubMed ID: 37708259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceroid lipofuscinosis in sheep. I. Bis(monoacylglycero)phosphate, dolichol, ubiquinone, phospholipids, fatty acids, and fluorescence in liver lipopigment lipids.
    Palmer DN; Husbands DR; Winter PJ; Blunt JW; Jolly RD
    J Biol Chem; 1986 Feb; 261(4):1766-72. PubMed ID: 3944107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipid composition and the lipolytic enzymes of the lysosomes].
    Lizenko EI
    Usp Sovrem Biol; 1982; 94(1):94-110. PubMed ID: 6753401
    [No Abstract]   [Full Text] [Related]  

  • 28. Biosynthesis of bis(monoacylglycero)phosphate in liver and macrophage lysosomes.
    Hostetler KY; Huterer SJ; Wherrett JR
    Methods Enzymol; 1992; 209():104-10. PubMed ID: 1495409
    [No Abstract]   [Full Text] [Related]  

  • 29. The active site and the phospholipid activation of rat liver lysosomal lipase are not stereospecific.
    Joutti A; Vainio P; Brotherus JR; Paltauf F; Kinnunen PK
    Chem Phys Lipids; 1981 Nov; 29(3):235-9. PubMed ID: 7296725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the occurrence and properties of lysosomal phospholipases A1 and A2 and the degradation of phosphatidic acid in rat liver lysosomes.
    Stoffel W; Trabert U
    Hoppe Seylers Z Physiol Chem; 1969 Jul; 350(7):836-44. PubMed ID: 4308852
    [No Abstract]   [Full Text] [Related]  

  • 31. Phospholipase A and acid lipase activity during release of lysosomal hydrolases.
    Weglicki WB; Ruth RC; Gottwik MG; Owens K; Griffin HD; Waite BM
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():49-59. PubMed ID: 5761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on lipids from liver and spleen of a child (O.L.) with Niemann-Pick's disease type C.
    Harder A; Widjaja F; Debuch H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):199-201. PubMed ID: 6716060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes.
    Hostetler KY; Reasor M; Yazaki PJ
    J Biol Chem; 1985 Jan; 260(1):215-9. PubMed ID: 3965448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the properties of phospholipase A1 in liver lysosomes of chloroquine-treated rats.
    Pakalapati G; Gunawan J; Debuch H
    Hoppe Seylers Z Physiol Chem; 1981 Nov; 362(11):1487-93. PubMed ID: 7309006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the liberation of fatty acids from 2-lysophosphatidylcholine by a liver lysosomal enzyme activity from chloroquine-treated rats.
    Pakalapati G; Debuch H
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):573-80. PubMed ID: 7106704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate.
    Pribasnig MA; Mrak I; Grabner GF; Taschler U; Knittelfelder O; Scherz B; Eichmann TO; Heier C; Grumet L; Kowaliuk J; Romauch M; Holler S; Anderl F; Wolinski H; Lass A; Breinbauer R; Marsche G; Brown JM; Zimmermann R
    J Biol Chem; 2015 Dec; 290(50):29869-81. PubMed ID: 26491015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bis(monoacylglycero)phosphate as a Macrophage Enriched Phospholipid.
    Akgoc Z; Iosim S; Seyfried TN
    Lipids; 2015 Sep; 50(9):907-12. PubMed ID: 26205346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The stereoconfiguration of newly formed molecules of bis(monoacylglycero)phosphate in BHK cells.
    Joutti A
    Biochim Biophys Acta; 1979 Oct; 575(1):10-5. PubMed ID: 508774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
    Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
    Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological substrates for human lysosomal beta -hexosaminidase S.
    Hepbildikler ST; Sandhoff R; Kolzer M; Proia RL; Sandhoff K
    J Biol Chem; 2002 Jan; 277(4):2562-72. PubMed ID: 11707436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.